Host: |
Rabbit |
Applications: |
IHC/IF/ELISA |
Reactivity: |
Human/Mouse |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Rabbit polyclonal antibody anti-Rho guanine nucleotide exchange factor 17 (431-480 aa) is suitable for use in Immunohistochemistry, Immunofluorescence and ELISA research applications. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide. |
Purification: |
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
Concentration: |
1 mg/mL |
Dilution Range: |
IHC 1:100-1:300IF 1:200-1:1000ELISA 1:5000 |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
ARHGEF17 |
Gene ID: |
9828 |
Uniprot ID: |
ARHGH_HUMAN |
Immunogen Region: |
431-480 aa |
Specificity: |
p164-RhoGEF Polyclonal Antibody detects endogenous levels of p164-RhoGEF protein. |
Immunogen: |
The antiserum was produced against synthesized peptide derived from the human ARHGEF17 at the amino acid range 431-480 |
Function | Acts as guanine nucleotide exchange factor (GEF) for RhoA GTPases. |
Protein Name | Rho Guanine Nucleotide Exchange Factor 17164 Kda Rho-Specific Guanine-Nucleotide Exchange FactorP164-RhogefP164rhogefTumor Endothelial Marker 4 |
Database Links | Reactome: R-HSA-193648Reactome: R-HSA-416482Reactome: R-HSA-8980692Reactome: R-HSA-9013026Reactome: R-HSA-9013106 |
Alternative Antibody Names | Anti-Rho Guanine Nucleotide Exchange Factor 17 antibodyAnti-164 Kda Rho-Specific Guanine-Nucleotide Exchange Factor antibodyAnti-P164-Rhogef antibodyAnti-P164rhogef antibodyAnti-Tumor Endothelial Marker 4 antibodyAnti-ARHGEF17 antibodyAnti-KIAA0337 antibodyAnti-TEM4 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance